Effect of dietary monosaccharides on pseudomonas aeruginosa virulence

Surgical Infections

Volumn 14, Issue 1, 2013, Pages 35-42

  Nelson, Ryan K ^a   Poroyko, Valeriy ^a   Morowitz, Michael J ^b   Liu, Don ^a   Alverdy, John C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; GALACTOSE; MANNOSE; XYLOSE;

ARTICLE; ARTIFICIAL MILK; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BIOFILM; BREAST MILK; CONTROLLED STUDY; DOWN REGULATION; FECES ANALYSIS; GENE EXPRESSION; GROWTH CURVE; METABOLOMICS; NECROTIZING ENTEROCOLITIS; NONHUMAN; NUTRIENT CONTENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

AEROBIOSIS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BIOFILMS; GENES, BACTERIAL; HUMANS; INFANT; INFANT FORMULA; MONOSACCHARIDES; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRULENCE;

EID: 84875184850     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.063     Document Type: Article

References (48)

1. Tsai F, Coyle WJ. The microbiome and obesity: Is obesity linked to our gut flora? Curr Gastroenterol Rep 2009;11:307-313.
2. Biasucci G, Rubini M, Riboni S, et al. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 2010;86(Suppl 1):13-15.
3. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002;68:219-226.
4. Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
5. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 2008;104:305-344.
6. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011;8:523-531.
7. Wallace TC, Guarner F, Madsen K, et al. Human gut mi-crobiota and its relationship to health and disease. Nutr Rev 2011;69:392-403.
8. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: Friends or foes? Nat Rev Immunol 2010;10:735-744.
9. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004;93:97-108.
10. Wardwell LH, Huttenhower C, Garrett WS. Current concepts of the intestinal microbiota and the pathogenesis of infection. Curr Infect Dis Rep 2011;13:28-34
11. Sisk PM, Lovelady CA, Dillard RG, et al. Early human milk feeding is associated with a lower risk of necrotizing en-terocolitis in very low birth weight infants. J Perinatol 2007;27:428-433.
12. Morowitz MJ, Poroyko V, Caplan M, et al. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics 2010;125:777-785.
13. Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 2003;8:449-459.
14. Gorke B, Stulke J. Carbon catabolite repression in bacteria: Many ways to make the most out of nutrients. Nat Rev Microbiol 2008;6:613-624.
15. Poncet S, Milohanic E, Maze A, et al. Correlations between carbon metabolism and virulence in bacteria. Contrib Mi-crobiol 2009;16:88-102.
16. Somerville GA, Proctor RA. At the crossroads of bacterial metabolism and virulence factor synthesis in staphylococci. Microbiol Mol Biol Rev 2009;73:233-248.
17. Cheng YL, Lee HC, Yeung CY, Chan WT. Clinical significance in previously healthy children of Pseudomonas aerugi-nosa in the stool. Pediatr Neonatol 2009;50:13-17.
18. Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004;48:2659-2664.
19. Harjai K, Khandwahaa RK, Mittal R, et al. Effect of pH on production of virulence factors by biofilm cells of Pseudo-monas aeruginosa. Folia Microbiol (Praha) 2005;50:99-102.
20. Kim EJ, Sabra W, Zeng AP. Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 2003;149:2627-2634.
21. Rau MH, Hansen SK, Johansen HK, et al. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 2010;12:1643-1658.
22. Sabra W, Kim EJ, Zeng AP. Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures. Microbiology 2002;148:3195-3202.
23. Sarkisova S, Patrauchan MA, Berglund D, et al. Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol 2005;187:4327-4337.
24. Shen L, Shi Y, Zhang D, et al. Modulation of secreted virulence factor genes by subinhibitory concentrations of antibiotics in Pseudomonas aeruginosa. J Microbiol 2008;46: 441-447.
25. Poroyko V, Morowitz M, Bell T, et al. Diet creates metabolic niches in the "immature gut" that shape microbial communities. Nutricion Hospitalaria 2011;26:1283-1295.
26. O'Toole GA, Pratt LA, Watnick PI, et al. Genetic approaches to study of biofilms. Methods Enzymol 1999;310:91-109.
27. Williams HD, Zlosnik JE, Ryall B. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomo-nas aeruginosa. Adv Microb Physiol 2007;52:1-71.
28. Dasgupta N, Wolfgang MC, Goodman AL, et al. A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 2003;50:809-824.
29. Ramphal R, Arora SK. Recognition of mucin components by Pseudomonas aeruginosa. Glycoconj J 2001;18:709-713.
30. Scharfman A, Arora SK, Delmotte P, et al. Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infect Immun 2001;69: 5243-5248.
31. Engel LS, Hill JM, Caballero AR, et al. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem 1998;273:16792-16797.
32. Winsor GL, Van Rossum T, Lo R, et al. Pseudomonas Genome Database: Facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res 2009;37: D483-D488.
33. Vinckx T, Wei Q, Matthijs S, Cornelis P. The Pseudomonas aeruginosa oxidative stress regulator OxyR influences production of pyocyanin and rhamnolipids: Protective role of pyocyanin. Microbiology 2010;156:678-686.
34. Rada B, Lekstrom K, Damian S, et al. The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. J Immunol 2008;181:4883-4893.
35. Heurlier K, Denervaud V, Haas D. Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int J Med Microbiol 2006;296:93-102.
36. Fuchs EL, Brutinel ED, Jones AK, et al. The Pseudomonas aeruginosa Vfr regulator controls global virulence factor expression through cAMP-dependent and-independent mechanisms. J Bacteriol 2010;192:3553-3564.
37. Hauser AR. The type III secretion system of Pseudomonas aeruginosa: Infection by injection. Nat Rev Microbiol 2009;7: 654-665.
38. Hahn HP. The type-4 pilus is the major virulence-Associated adhesin of Pseudomonas aeruginosa: A review. Gene 1997;192: 99-108.
39. Whitchurch CB, Leech AJ, Young MD, et al. Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa. Mol Microbiol 2004;52:873-893.
40. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000;406:959-964.
41. Sonnleitner E, Abdou L, Haas D. Small RNA as global regulator of carbon catabolite repression in Pseudomonas aeru-ginosa. Proc Natl Acad Sci USA 2009;106:21866-21871.
42. Rojo F. Carbon catabolite repression in Pseudomonas: Optimizing metabolic versatility and interactions with the environment. FEMS Microbiol Rev 2010;34:658-684.
43. Hoskins LC, Boulding ET. Mucin degradation in human colon ecosystems: Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. J Clin Invest 1981;67:163-172.
44. Ohara T, Itoh K. Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract. Intern Med 2003;42: 1072-1076.
45. Issa M, Saeian K. Diet in inflammatory bowel disease. Nutr Clin Pract 2011;26:151-154.
46. Marcobal A, Barboza M, Froehlich JW, et al. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem 2010;58:5334-5340.
47. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-594.
48. Patwa LG, Fan TJ, Tchaptchet S, et al. Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 2011;141:1842-1851.